Mises à jour et perles d’informations de l’assemblée de la Society of Pediatric Dermatology
Résumé
La 49e assemblée annuelle de la Society of Pediatric Dermatology (SPD) fut un énorme succès, attirant plus de 650 participants, le plus grand nombre jamais enregistré. La conférence de trois jours a présenté un large éventail de nouvelles avancées, de même que des conseils et des astuces de la part d’experts dans le domaine. Les participants ont profité des magnifiques sites et des spécialités culinaires de Toronto tout en bravant une alarme de feu et des fientes d’oiseaux.
Références
Metry D, Copp HL, Rialon KL, Iacobas I, Baselga E, Dobyns WB, et al. Delphi Consensus on diagnostic criteria for LUMBAR syndrome. J Pediatr. 2024;272:114101. doi:10.1016/j.jpeds.2024.114101
Swonke ML, Smith SA, Ohlstein JF, Siddiqui F, Szeremeta W, Pine HS. Unexplained destructive nasal lesions in half-brothers: a possible case of Munchausen syndrome by proxy. Int J Pediatr Otorhinolaryngol. 2019;123:75-78. doi:10.1016/j.ijporl.2019.04.029
Kellogg ND, Farst KJ, Adams JA. Interpretation of medical findings in suspected child sexual abuse: an update for 2023. Child Abuse Negl. 2023;145:106283. doi:10.1016/j.chiabu.2023.106283
Kostopoulou E, Anagnostis P, Bosdou JK, Spiliotis BE, Goulis DG. Polycystic ovary syndrome in adolescents: pitfalls in diagnosis and management. Curr Obes Rep. 2020;9(3):193-203. doi:10.1007/s13679-020-00388-9
Bhatti S, Hussain S, Zaenglein A. Safety of sprionolactone use in children and adolescents: a systematic review. The 8th Annual Pediatric Dermatology Research Alliance (PeDRA) Meeting; October 22-23, 2020; Virtual2020.
Powell A. Choosing the right oral contraceptive pill for teens. Pediatr Clin North Am. 2017;64(2):343-358. doi:10.1016/j.pcl.2016.11.005
Pope E, Lara-Corrales I, Sibbald C, Liy-Wong C, Kanigsberg N, Drolet B, et al. Noninferiority and safety of nadolol vs propranolol in infants with infantile hemangioma: a randomized clinical trial. JAMA Pediatr. 2022;176(1):34-41. doi:10.1001/jamapediatrics.2021.4565
Roerdink EM, Flokstra-de Blok BM, Blok JL, Schuttelaar ML, Niggemann B, Werfel T, et al. Association of food allergy and atopic dermatitis exacerbations. Ann Allergy Asthma Immunol. 2016;116(4):334-338. doi:10.1016/j.anai.2016.01.022
Renert-Yuval Y, Ezzedine K, Grimes P, Rosmarin D, Eichenfield LF, Castelo-Soccio L, et al. Expert recommendations on use of topical therapeutics for vitiligo in pediatric, adolescent, and young adult patients. JAMA Dermatol. 2024;160(4):453-461. doi:10.1001/jamadermatol.2024.0021
Herskovitz I, Miteva M. Central centrifugal cicatricial alopecia: challenges and solutions. Clin Cosmet Investig Dermatol. 2016;9:175-181. doi:10.2147/ccid.S100816
Guo YX, Wang HX, Wang SS, Croitoru D, Piguet V, Gao XH, et al. Treatment with selumetinib for Café-au-Lait macules and plexiform neurofibroma in pediatric patients with Neurofibromatosis Type 1. JAMA Dermatol. 2024;160(3):366-368. doi:10.1001/jamadermatol.2023.5338
Borgia P, Piccolo G, Santangelo A, Chelleri C, Viglizzo G, Occella C, et al. Dermatologic effects of selumetinib in pediatric patients with Neurofibromatosis Type 1: clinical challenges and therapeutic management. J Clin Med. 2024;13(6). doi:10.3390/jcm13061792
Haller CN, Leszczynska MA, Brichta L, Maier E, Riddington IM, Choate KA, et al. Topical trametinib for epidermal and sebaceous nevi in a child with Schimmelpenning-Feuerstein-Mims syndrome. Pediatr Dermatol. 2024;41(3):523-525. doi:10.1111/pde.15523
Lieberman JA, Chu DK, Ahmed T, Dribin TE, Abrams EM, Anagnostou A, et al. A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: a position paper of the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 2024. doi:10.1016/j.anai.2024.05.014
Eickstaedt JB, Starke S, Krakora D, Hinshaw M, Arkin LM. Clearance of pediatric actinic prurigo with dupilumab. Pediatr Dermatol. 2020;37(6):1176-1178. doi:10.1111/pde.14311
Netravali IA, Sockler PG, Heimall J, Treat JR. Rapid resolution of diffuse warts following initiation of dupilumab for severe atopic dermatitis. Pediatr Dermatol. 2024;41(2):275-278. doi:10.1111/pde.15414
Rodriguez-Lago L, Borrego L. Norwegian Scabies in an atopic patient under dupilumab treatment. Dermatitis. 2022;33(5):e54-e55. doi:10.1097/der.0000000000000926
Krakowski AC, Senft SC, Heymann WR. Demodex Folliculitis and recent dupilumab administration. Pediatrics. 2021;147(5). doi:10.1542/peds.2020-029520
Siegfried EC, Arkin LM, Chiu YE, Hebert AA, Callen JP, Castelo-Soccio L, et al. Methotrexate for inflammatory skin disease in pediatric patients: consensus treatment guidelines. Pediatr Dermatol. 2023;40(5):789-808. doi:10.1111/pde.15327
CenterWatch. FDA Approved Drugs. Princeton, NJ: WCG Company; 2024 [Accessed 28 July 2024] Available from: https://www.centerwatch.com/directories/1067-fda-approved-drugs.
